FDA
-
-
-
-
-
-
-
STAAR Surgical Issues Shareholder Letter
-
-
-
-
-
-
-
STAAR Surgical (STAA) Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors
-
-
-
-
-
-
-
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
-
-
-
-
-
-
-
STAAR Surgical (STAA) Announces CEO Retirement, Appoints Tom Frinzi as Replacement
-
-
-
-
-
-
-
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
-
-
-
-
-
-
-
STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y
-
-
-
-
-
-
-
STAAR Surgical (STAA) Announces FDA IDE Clinical Study Approval
-
326,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

